# Gleamer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gleamer

- Industry: Medical Devices & Equipment
- Headquarters: France
- Website: www.gleamer.ai/
- Total disclosed funding: $38M
- Latest round: Series B (Jun 28, 2023)
- Investors on record: 9

## About

Gleamer Sas, based in France, specializes in artificial intelligence solutions that enhance radiology workflows and improve diagnostic accuracy for healthcare institutions.Gleamer Sas was founded in 2017 in France, focusing on developing AI-driven solutions for medical imaging. The company has undergone no notable pivots in its business strategy. Its founders are Alexis Ducarouge, Christian Allouche, Katie Ford, and Nor-eddine Regnard, with Christian Allouche currently serving as the CEO. In March 2026, RadNet Management, Inc. acquired Gleamer Sas from?Elaia Partners, XAnge, Bpifrance Investissement Régions, Kima Ventures, MACSF, Crista Galli Ventures, Majycc eSante Invest, UI Investissement, Supernova Invest, Heal Capital, and Government of France. Financial terms were not disclosed.Gleamer specializes in innovative artificial intelligence solutions designed to enhance radiology workflows and improve diagnostic accuracy. Their flagship products include Gleamer BoneView, which establishes a new standard in bone trauma interpretation, and Gleamer ChestView, aimed at enhancing the detection of urgent and cancerous findings in chest imaging. Additionally, Gleamer offers BoneMetrics for automated musculoskeletal measurements, BoneAge for precise age assessments beyond traditional atlases, and BreastView, a precision AI tool for early breast cancer detection. These products are primarily utilized by healthcare institutions across various countries, supporting medical professionals in over 45 nations, with a client base encompassing more than 2,000 health institutions and facilitating approximately 35 million patient exams annually. The company emphasizes compliance with international certifications, ensuring their solutions effectively meet the needs of diverse healthcare environments.Gleamer's revenue model is primarily built on B2B transactions, where the company partners with healthcare institutions to integrate its AI solutions into existing radiology systems. The firm operates through a subscription-based model, allowing clients to access and utilize their products over specified periods, which may include licensing fees for each institution or exam conducted. Each product, such as Gleamer BoneView and BreastView, is tailored to address specific clinical needs. The structure of these partnerships typically involves direct contracts with hospitals and medical facilities, ensuring that services are delivered consistently and effectively. Given the scalability of AI solutions in medical imaging, Gleamer's offerings are designed to streamline workflows and improve patient care, fostering long-term relationships with healthcare providers. The acquisition aims to expand artificial intelligence capabilities in medical imaging and address rising imaging demand amid a shortage of radiologists.

## Funding rounds

- Series B, Jun 28, 2023, $29M — Elaia Partners, MACSF, XAnge, UI Investissement, Bpifrance Investissement Régions, Supernova Invest, Crista Galli Ventures, Heal Capital
- Series A, Sep 24, 2020, $8.9M — Elaia Partners, MACSF, XAnge, Bpifrance Investissement Régions, Crista Galli Ventures, Majycc eSante Invest

## Investors

- Elaia Partners (https://capitalatlas.ai/funds/elaia-partners) — Series A, Series B
- MACSF — Series A, Series B
- XAnge (https://capitalatlas.ai/funds/xange) — Series A, Series B
- Bpifrance Investissement Régions (https://capitalatlas.ai/funds/bpifrance-investissement-regions) — Series A, Series B
- Crista Galli Ventures (https://capitalatlas.ai/funds/crista-galli-ventures) — Series A, Series B
- Majycc eSante Invest (https://capitalatlas.ai/funds/majycc-esante-invest) — Series A
- UI Investissement (https://capitalatlas.ai/funds/ui-investissement) — Series B
- Supernova Invest (https://capitalatlas.ai/funds/supernova-invest) — Series B
- Heal Capital (https://capitalatlas.ai/funds/heal-capital) — Series B